文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急诊科鼻咽拭子SARS-CoV-2病毒载量不能预测COVID-19严重程度和死亡率

SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.
PubMed 文献 · Acad Emerg Med · 2021-02-05
一句话结论急诊首次鼻咽拭子RT-PCR病毒载量既不预测COVID-19严重程度,也不预测院内死亡,不应据此分流或判断预后。

这项在法国斯特拉斯堡大学医院开展的回顾性队列研究纳入287例急诊就诊后住院、住院期间至少一次鼻咽拭子阳性的COVID-19患者,其中49.5%为需要机械通气的重症。入院首次上呼吸道拭子病毒载量中位数为4.76 log10 copies/reaction(IQR 3.29-6.06)。病毒载量与生存/死亡亚组无关(p=0.332),校正后既不预测院内死亡(AOR=1.05,95%CI 0.85-1.31,p=0.637),也不预测疾病严重程度(AOR=0.88,95%CI 0.73-1.06,p=0.167)。提示急诊不应以病毒载量高低判断病情或决定处置强度。

要点

  • 急诊首次鼻咽拭子病毒载量中位数4.76 log10 copies/reaction(IQR 3.29-6.06),与生存/死亡亚组无差异(p=0.332)。
  • 校正后病毒载量不预测院内死亡:AOR=1.05(95%CI 0.85-1.31,p=0.637)。
  • 校正后病毒载量不预测疾病严重程度:AOR=0.88(95%CI 0.73-1.06,p=0.167)。
  • 研究队列中49.5%为需机械通气的重症,提示即使重症比例高,病毒载量仍无预后价值。
  • 临床判断病情应依据宿主反应和基础合并症,而非上呼吸道病毒载量数值。

适用人群与场景

  • 2020年3月3日至4月5日在法国斯特拉斯堡大学医院急诊就诊后住院、住院期间至少一次鼻咽拭子SARS-CoV-2 RT-PCR阳性的COVID-19患者(轻症或重症均可纳入)。
  • 原文未明确列出排除标准。

诊断标准与关键阈值

  • COVID-19确诊依据:鼻咽拭子SARS-CoV-2 RT-PCR阳性。
  • 疾病严重程度分组:轻症 vs 重症(重症定义为需要机械通气)。
  • 病毒载量以log10 copies/reaction表示,取自入院首次上呼吸道拭子。

处置流程与药物剂量

  • 原文未提及基于病毒载量的具体处置流程或药物方案。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:回顾性队列研究,单中心(法国斯特拉斯堡大学医院),样本量287例COVID-19住院患者。
  • 人群:急诊就诊后住院、至少一次鼻咽拭子阳性的COVID-19患者,50.5%轻症,49.5%重症需机械通气。
  • 暴露/指标:入院首次鼻咽拭子RT-PCR病毒载量,中位数4.76 log10 copies/reaction(IQR 3.29-6.06)。
  • 主要终点:病毒载量与院内死亡无关(校正OR=1.05,95%CI 0.85-1.31,p=0.637)。
  • 关键次要终点:病毒载量与疾病严重程度无关(校正OR=0.88,95%CI 0.73-1.06,p=0.167);生存者与死亡者病毒载量无差异(p=0.332)。

证据类型、等级与局限

  • 证据类型:单中心回顾性队列研究。
  • 局限:回顾性设计、单中心、样本量287例;原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 急诊对COVID-19患者不应依据首次鼻咽拭子病毒载量高低判断病情严重程度或预测院内死亡。
  • 病毒载量不能作为分流、收入ICU或决定治疗强度的依据;病情评估应结合宿主反应和基础合并症(原文结论性表述)。
  • 原文未提及适用与不适用人群的进一步限定,也未提及常见陷阱。

指南或共识出处

  • Acad Emerg Med 发表的原始研究:SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality.

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

INTRODUCTION: The ongoing COVID-19 pandemic has led to devastating repercussions on health care systems worldwide. This viral infection has a broad clinical spectrum (ranging from influenza-like disease, viral pneumonia, and hypoxemia to acute respiratory distress syndrome requiring prolonged intensive care unit stays). The prognostic impact of measuring viral load on nasopharyngeal swab specimens (by reverse transcriptase polymerase chain reaction [RT-PCR]) is yet to be elucidated.

METHODS: Between March 3 and April 5, 2020, we conducted a retrospective study on a cohort of COVID-19 patients (mild or severe disease) who were hospitalized after presenting to the emergency department (ED) and had at least one positive nasopharyngeal swab during their hospital stay. We led our study at the University Hospitals of Strasbourg in the Greater East region of France, one of the pandemic's epicenters in Europe.

RESULTS: We have collected samples from a cohort of 287 patients with a confirmed diagnosis of COVID-19 who were included in our study. Nearly half of them (50.5%) presented a mild form of the disease, while the other half (49.5%) presented a severe form, requiring mechanical ventilation. Median (interquartile range) viral load on the initial upper respiratory swab at admission was 4.76 (3.29-6.06) log10 copies/reaction. When comparing survivors and nonsurvivors, this viral load measurement did not differ according to subgroups (p = 0.332). Additionally, we have found that respiratory viral load measurement was predictive of neither in-hospital mortality (adjusted odds ratio [AOR] = 1.05, 95% confidence interval [CI] = 0.85 to 1.31, p = 0.637) nor disease severity (AOR = 0.88, 95% CI = 0.73 to 1.06, p = 0.167).

CONCLUSION: Respiratory viral load measurement on the first nasopharyngeal swab (by RT-PCR) during initial ED management is neither a predictor of severity nor a predictor of mortality in SARS-CoV-2 infection. Host response to this viral infection along with the extent of preexisting comorbidities might be more foretelling of disease severity than the virus itself.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Le Borgne P, Solis M, Severac F, et al. SARS-CoV-2 viral load in nasopharyngeal swabs in the emergency department does not predict COVID-19 severity and mortality. Acad Emerg Med. 2021. PMID: 33481307. doi:10.1111/acem.14217

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。